Anti-malarial, Cytotoxicity and Molecular Docking Studies of Quinolinyl Chalcones As Potential Anti-malarial Agent

Overview

Journal J Comput Aided Mol Des

Publisher Springer

Specialties Biomedical Engineering
Molecular Biology

Date 2019 Jul 5

PMID 31270655

Citations 3

Authors

Asima Hameed

Sara Masood

Aamir Hameed

Ejaz Ahmed

Ahsan Sharif

Muhammad Imran Abdullah

Affiliations

Soon will be listed here.

Abstract

The quinolinyl chalcones series (A-A) were screened for antimalarial activity. According to in vitro antimalarial studies, many quinolinyl chalcones are potentially active against CQ-sensitive and resistance P. falciparum strains with no toxicity against Vero cell lines. The most active quinolinyl chalcones A (with IC 0.031 μM) made a stable A-heme complex with - 25 kcal/mole binding energy and also showed strong π-π interaction at 3.5 Å. Thus, the stable A-heme complex formation suggested that these quinolinyl chalcones act as a blocker for heme polymerization. The docking results of quinolinyl chalcones with Pf-DHFR showed that the halogenated benzene part of quinolinyl chalcones made strong interaction with Pf-DHFR as compared to quinoline part. A strong A-Pf-DHFR complex was formed with low binding energy (- 11.04 kcal/mole). The ADMET properties of quinolinyl chalcones were also studied. The in vivo antimalarial studies also confirmed the A as an active antimalarial agent.

Citing Articles

Computational investigation of naturally occurring anticancer agents in regulating Hedgehog pathway proteins.

Pai R, Sirigiri D, Malempati R, Vinjamuri S PLoS One. 2024; 19(12):e0311307.

PMID: 39625914 PMC: 11614240. DOI: 10.1371/journal.pone.0311307.

Chalcone: A Promising Bioactive Scaffold in Medicinal Chemistry.

Rajendran G, Bhanu D, Aruchamy B, Ramani P, Pandurangan N, Bobba K Pharmaceuticals (Basel). 2022; 15(10).

PMID: 36297362 PMC: 9607481. DOI: 10.3390/ph15101250.

Synthesis, characterization, molecular docking, antimalarial, and antiproliferative activities of benzyloxy-4-oxopyridin benzoate derivatives.

Mohebi M, Fayazi N, Esmaeili S, Rostami M, Bagheri F, Aliabadi A Res Pharm Sci. 2022; 17(3):252-264.

PMID: 35531137 PMC: 9075022. DOI: 10.4103/1735-5362.343079.

References

Ertl P, Rohde B, Selzer P . Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem. 2000; 43(20):3714-7. DOI: 10.1021/jm000942e. View

Breman J . The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am J Trop Med Hyg. 2001; 64(1-2 Suppl):1-11. DOI: 10.4269/ajtmh.2001.64.1. View

Mendis K, Sina B, Marchesini P, Carter R . The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001; 64(1-2 Suppl):97-106. DOI: 10.4269/ajtmh.2001.64.97. View

Dominguez J, Charris J, Lobo G, Gamboa de Dominguez N, Moreno M, Riggione F . Synthesis of quinolinyl chalcones and evaluation of their antimalarial activity. Eur J Med Chem. 2001; 36(6):555-60. DOI: 10.1016/s0223-5234(01)01245-4. View

Le Tran Q, Tezuka Y, Ueda J, Nguyen N, Maruyama Y, Begum K . In vitro antiplasmodial activity of antimalarial medicinal plants used in Vietnamese traditional medicine. J Ethnopharmacol. 2003; 86(2-3):249-52. DOI: 10.1016/s0378-8741(03)00045-x. View

Cohen S, PHIFER K, Yielding K . COMPLEX FORMATION BETWEEN CHLOROQUINE AND FERRIHAEMIC ACID IN VITRO, AND ITS EFFECT ON THE ANTIMALARIAL ACTION OF CHLOROQUINE. Nature. 1964; 202:805-6. DOI: 10.1038/202805a0. View

KOENIG D . THE STRUCTURE OF ALPHA-CHLOROHEMIN. Acta Crystallogr. 1965; 18:663-73. DOI: 10.1107/s0365110x65001536. View

White N . Antimalarial drug resistance. J Clin Invest. 2004; 113(8):1084-92. PMC: 385418. DOI: 10.1172/JCI21682. View

Xue C, Cui S, Liu M, Hu Z, Fan B . 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA. Eur J Med Chem. 2004; 39(9):745-53. DOI: 10.1016/j.ejmech.2004.05.009. View

10.

Bender A, Glen R . Molecular similarity: a key technique in molecular informatics. Org Biomol Chem. 2004; 2(22):3204-18. DOI: 10.1039/B409813G. View

11.

Tekwani B, Walker L . Targeting the hemozoin synthesis pathway for new antimalarial drug discovery: technologies for in vitro beta-hematin formation assay. Comb Chem High Throughput Screen. 2005; 8(1):63-79. DOI: 10.2174/1386207053328101. View

12.

Jain M, Khan S, Tekwani B, Jacob M, Singh S, Singh P . Synthesis, antimalarial, antileishmanial, and antimicrobial activities of some 8-quinolinamine analogues. Bioorg Med Chem. 2005; 13(14):4458-66. DOI: 10.1016/j.bmc.2005.04.034. View

13.

Dominguez J, Leon C, Rodrigues J, de Dominguez N, Gut J, Rosenthal P . Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives. J Med Chem. 2005; 48(10):3654-8. DOI: 10.1021/jm058208o. View

14.

Kumar S, Guha M, Choubey V, Maity P, Bandyopadhyay U . Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. Life Sci. 2006; 80(9):813-28. DOI: 10.1016/j.lfs.2006.11.008. View

15.

Slater A, Cerami A . Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature. 1992; 355(6356):167-9. DOI: 10.1038/355167a0. View

16.

Warhurst D, Craig J, Adagu I, Guy R, Madrid P, Fivelman Q . Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases. Biochem Pharmacol. 2007; 73(12):1910-26. DOI: 10.1016/j.bcp.2007.03.011. View

17.

Aponte J, Aide P, Renom M, Mandomando I, Bassat Q, Sacarlal J . Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet. 2007; 370(9598):1543-51. DOI: 10.1016/S0140-6736(07)61542-6. View

18.

Gacche R, Khsirsagar M, Kamble S, Bandgar B, Dhole N, Shisode K . Antioxidant and anti-inflammatory related activities of selected synthetic chalcones: structure-activity relationship studies using computational tools. Chem Pharm Bull (Tokyo). 2008; 56(7):897-901. DOI: 10.1248/cpb.56.897. View

19.

Weissbuch I, Leiserowitz L . Interplay between malaria, crystalline hemozoin formation, and antimalarial drug action and design. Chem Rev. 2008; 108(11):4899-914. DOI: 10.1021/cr078274t. View

20.

Vekemans J, Marsh K, Greenwood B, Leach A, Kabore W, Soulanoudjingar S . Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care. Malar J. 2011; 10:221. PMC: 3221632. DOI: 10.1186/1475-2875-10-221. View